Top Stories
The neurotech startup has also undergone a restructuring that will see it shed jobs and scale back its operations in New York.
Patients with advanced NSCLC who underwent comprehensive genomic testing before first-line therapy were more likely to receive targeted treatments than those given narrower tests.
The French startup plans to expand its AI platform beyond colorectal and pancreatic cancers, using lab-grown patient tumours to predict how experimental drugs will perform in clinical trials.
The findings highlight the importance of looking beyond calcium and plaque to assess cardiovascular risk.
The Wellderly Brain Study is testing whether digital lifestyle coaching can influence Alzheimer's biomarkers, particularly p-tau217, as well as measures of cognitive and biological ageing.
Conference News
Statistically significant reductions in food noise scores from baseline were observed in adults taking semaglutide injection within the first month of initiation and through six months in the SIGNAL s...
KEARNY, N.J. and TEL AVIV, Israel, Nov. 15, 2026 (GLOBE NEWSWIRE) -- NeuroKaire, turning a simple blood draw into a window on each patient’s brain, today announced its participation at the HLTH 2026 C...
Signals in the brain, blood, and body are changing the diagnosis and treatment of neurological and psychiatric conditionsSociety for NeuroscienceWASHINGTON, D.C. — Newly developed biomarkers may enhan...
Implanted devices decode brain activity to give users a voice againSociety for NeuroscienceWASHINGTON, D.C. — Recent advancements in brain-computer interfaces are helping restore communication in clin...
Interplay between AI and neuroscience is advancing understanding of both brains and artificial systemsSociety for NeuroscienceWASHINGTON, D.C. — Integrating artificial intelligence (AI) into neuroscie...



